nodes	percent_of_prediction	percent_of_DWPC	metapath
Lenalidomide—TNFSF11—rheumatoid arthritis	0.475	0.912	CbGaD
Lenalidomide—PTGS2—rheumatoid arthritis	0.0461	0.0886	CbGaD
Lenalidomide—PTGS2—Triamcinolone—rheumatoid arthritis	0.0401	0.184	CbGbCtD
Lenalidomide—PTGS2—Sulfasalazine—rheumatoid arthritis	0.0401	0.184	CbGbCtD
Lenalidomide—PTGS2—Betamethasone—rheumatoid arthritis	0.0344	0.158	CbGbCtD
Lenalidomide—PTGS2—Dexamethasone—rheumatoid arthritis	0.02	0.0919	CbGbCtD
Lenalidomide—ABCB1—Methylprednisolone—rheumatoid arthritis	0.0174	0.0802	CbGbCtD
Lenalidomide—TNFSF11—skeletal joint—rheumatoid arthritis	0.0144	0.248	CbGeAlD
Lenalidomide—ABCB1—Betamethasone—rheumatoid arthritis	0.0113	0.0521	CbGbCtD
Lenalidomide—ABCB1—Prednisolone—rheumatoid arthritis	0.0112	0.0514	CbGbCtD
Lenalidomide—TNFSF11—synovial membrane of synovial joint—rheumatoid arthritis	0.0109	0.188	CbGeAlD
Lenalidomide—ABCB1—Hydrocortisone—rheumatoid arthritis	0.0106	0.0487	CbGbCtD
Lenalidomide—ABCB1—Prednisone—rheumatoid arthritis	0.0106	0.0486	CbGbCtD
Lenalidomide—ABCB1—Cyclosporine—rheumatoid arthritis	0.01	0.046	CbGbCtD
Lenalidomide—TNFSF11—cartilage tissue—rheumatoid arthritis	0.00968	0.167	CbGeAlD
Lenalidomide—ABCB1—Dexamethasone—rheumatoid arthritis	0.0066	0.0303	CbGbCtD
Lenalidomide—ABCB1—Methotrexate—rheumatoid arthritis	0.0053	0.0244	CbGbCtD
Lenalidomide—TNFSF11—connective tissue—rheumatoid arthritis	0.00241	0.0414	CbGeAlD
Lenalidomide—CDH5—parotid gland—rheumatoid arthritis	0.00206	0.0354	CbGeAlD
Lenalidomide—PTGS2—skeletal joint—rheumatoid arthritis	0.00187	0.0322	CbGeAlD
Lenalidomide—CDH5—connective tissue—rheumatoid arthritis	0.00181	0.0312	CbGeAlD
Lenalidomide—TNFSF11—lymphoid tissue—rheumatoid arthritis	0.00176	0.0303	CbGeAlD
Lenalidomide—TNFSF11—tendon—rheumatoid arthritis	0.00166	0.0285	CbGeAlD
Lenalidomide—Thalidomide—NFKB1—rheumatoid arthritis	0.00165	0.464	CrCbGaD
Lenalidomide—PTGS2—synovial membrane of synovial joint—rheumatoid arthritis	0.00142	0.0245	CbGeAlD
Lenalidomide—CDH5—lymphoid tissue—rheumatoid arthritis	0.00132	0.0228	CbGeAlD
Lenalidomide—CRBN—parotid gland—rheumatoid arthritis	0.00131	0.0225	CbGeAlD
Lenalidomide—PTGS2—cartilage tissue—rheumatoid arthritis	0.00126	0.0217	CbGeAlD
Lenalidomide—CRBN—saliva-secreting gland—rheumatoid arthritis	0.00125	0.0215	CbGeAlD
Lenalidomide—CDH5—tendon—rheumatoid arthritis	0.00125	0.0214	CbGeAlD
Lenalidomide—CRBN—lymphoid tissue—rheumatoid arthritis	0.000841	0.0145	CbGeAlD
Lenalidomide—CRBN—digestive system—rheumatoid arthritis	0.000831	0.0143	CbGeAlD
Lenalidomide—CRBN—tendon—rheumatoid arthritis	0.000791	0.0136	CbGeAlD
Lenalidomide—Pomalidomide—TNF—rheumatoid arthritis	0.000786	0.221	CrCbGaD
Lenalidomide—Thalidomide—TNF—rheumatoid arthritis	0.000507	0.142	CrCbGaD
Lenalidomide—Pomalidomide—PTGS2—rheumatoid arthritis	0.000373	0.105	CrCbGaD
Lenalidomide—PTGS2—Fluocinonide—Methylprednisolone—rheumatoid arthritis	0.000325	0.159	CbGdCrCtD
Lenalidomide—PTGS2—Fluocinonide—Betamethasone—rheumatoid arthritis	0.00032	0.156	CbGdCrCtD
Lenalidomide—PTGS2—Fluocinonide—Dexamethasone—rheumatoid arthritis	0.00032	0.156	CbGdCrCtD
Lenalidomide—PTGS2—connective tissue—rheumatoid arthritis	0.000313	0.00539	CbGeAlD
Lenalidomide—PTGS2—Fluocinonide—Triamcinolone—rheumatoid arthritis	0.000312	0.153	CbGdCrCtD
Lenalidomide—Thalidomide—PTGS2—rheumatoid arthritis	0.000241	0.0676	CrCbGaD
Lenalidomide—PTGS2—lymphoid tissue—rheumatoid arthritis	0.000229	0.00394	CbGeAlD
Lenalidomide—PTGS2—digestive system—rheumatoid arthritis	0.000226	0.00389	CbGeAlD
Lenalidomide—PTGS2—tendon—rheumatoid arthritis	0.000215	0.0037	CbGeAlD
Lenalidomide—PTGS2—Fluticasone Propionate—Methylprednisolone—rheumatoid arthritis	0.000196	0.0958	CbGdCrCtD
Lenalidomide—PTGS2—Fluticasone Propionate—Betamethasone—rheumatoid arthritis	0.000193	0.0943	CbGdCrCtD
Lenalidomide—PTGS2—Fluticasone Propionate—Dexamethasone—rheumatoid arthritis	0.000193	0.0943	CbGdCrCtD
Lenalidomide—PTGS2—Fluticasone Propionate—Triamcinolone—rheumatoid arthritis	0.000188	0.0921	CbGdCrCtD
Lenalidomide—ABCB1—lymphoid tissue—rheumatoid arthritis	0.000142	0.00244	CbGeAlD
Lenalidomide—ABCB1—digestive system—rheumatoid arthritis	0.00014	0.00241	CbGeAlD
Lenalidomide—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CSF2—rheumatoid arthritis	8.59e-05	0.00123	CbGpPWpGaD
Lenalidomide—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—CDK6—rheumatoid arthritis	8.56e-05	0.00123	CbGpPWpGaD
Lenalidomide—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL4—rheumatoid arthritis	8.45e-05	0.00121	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—RBPJ—rheumatoid arthritis	8.45e-05	0.00121	CbGpPWpGaD
Lenalidomide—PTGS2—Selenium Micronutrient Network—SAA1—rheumatoid arthritis	8.38e-05	0.0012	CbGpPWpGaD
Lenalidomide—PTGS2—S1P1 pathway—VEGFA—rheumatoid arthritis	8.36e-05	0.0012	CbGpPWpGaD
Lenalidomide—PTGS2—C-MYB transcription factor network—GATA3—rheumatoid arthritis	8.27e-05	0.00119	CbGpPWpGaD
Lenalidomide—PTGS2—Spinal Cord Injury—COL2A1—rheumatoid arthritis	8.16e-05	0.00117	CbGpPWpGaD
Lenalidomide—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—FASLG—rheumatoid arthritis	8.07e-05	0.00116	CbGpPWpGaD
Lenalidomide—ABCB1—Allograft Rejection—FOXP3—rheumatoid arthritis	7.98e-05	0.00114	CbGpPWpGaD
Lenalidomide—ABCB1—HIF-1-alpha transcription factor network—ETS1—rheumatoid arthritis	7.93e-05	0.00114	CbGpPWpGaD
Lenalidomide—PTGS2—Calcium signaling in the CD4+ TCR pathway—IFNG—rheumatoid arthritis	7.89e-05	0.00113	CbGpPWpGaD
Lenalidomide—PTGS2—Spinal Cord Injury—C5—rheumatoid arthritis	7.88e-05	0.00113	CbGpPWpGaD
Lenalidomide—PTGS2—C-MYB transcription factor network—CDK6—rheumatoid arthritis	7.84e-05	0.00112	CbGpPWpGaD
Lenalidomide—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2RA—rheumatoid arthritis	7.74e-05	0.00111	CbGpPWpGaD
Lenalidomide—ABCB1—Allograft Rejection—C5—rheumatoid arthritis	7.7e-05	0.0011	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—CXCL13—rheumatoid arthritis	7.46e-05	0.00107	CbGpPWpGaD
Lenalidomide—ABCB1—HIF-1-alpha transcription factor network—ENO1—rheumatoid arthritis	7.25e-05	0.00104	CbGpPWpGaD
Lenalidomide—PTGS2—Overview of nanoparticle effects—TNF—rheumatoid arthritis	7.17e-05	0.00103	CbGpPWpGaD
Lenalidomide—PTGS2—Spinal Cord Injury—FCGR2A—rheumatoid arthritis	7.07e-05	0.00101	CbGpPWpGaD
Lenalidomide—PTGS2—Calcium signaling in the CD4+ TCR pathway—IL2—rheumatoid arthritis	7.01e-05	0.00101	CbGpPWpGaD
Lenalidomide—ABCB1—Allograft Rejection—GZMB—rheumatoid arthritis	6.82e-05	0.000978	CbGpPWpGaD
Lenalidomide—PTGS2—Spinal Cord Injury—CXCL2—rheumatoid arthritis	6.78e-05	0.000971	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—TLE3—rheumatoid arthritis	6.72e-05	0.000962	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—IRAK1—rheumatoid arthritis	6.72e-05	0.000962	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—CX3CR1—rheumatoid arthritis	6.65e-05	0.000953	CbGpPWpGaD
Lenalidomide—ABCB1—HIF-1-alpha transcription factor network—CXCL12—rheumatoid arthritis	6.5e-05	0.000932	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—IL2RB—rheumatoid arthritis	6.4e-05	0.000917	CbGpPWpGaD
Lenalidomide—ABCB1—Allograft Rejection—IL17A—rheumatoid arthritis	6.28e-05	0.0009	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—C5—rheumatoid arthritis	6.18e-05	0.000886	CbGpPWpGaD
Lenalidomide—ABCB1—Allograft Rejection—CD28—rheumatoid arthritis	6.1e-05	0.000874	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—NFATC1—rheumatoid arthritis	6.08e-05	0.000871	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism of lipids and lipoproteins—FADS2—rheumatoid arthritis	6.05e-05	0.000867	CbGpPWpGaD
Lenalidomide—PTGS2—Selenium Micronutrient Network—CAT—rheumatoid arthritis	5.85e-05	0.000838	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—CCR6—rheumatoid arthritis	5.81e-05	0.000833	CbGpPWpGaD
Lenalidomide—ABCB1—Allograft Rejection—HLA-DPB1—rheumatoid arthritis	5.79e-05	0.00083	CbGpPWpGaD
Lenalidomide—PTGS2—Overview of nanoparticle effects—IL6—rheumatoid arthritis	5.78e-05	0.000829	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—NCF2—rheumatoid arthritis	5.65e-05	0.00081	CbGpPWpGaD
Lenalidomide—ABCB1—Allograft Rejection—CXCL12—rheumatoid arthritis	5.63e-05	0.000807	CbGpPWpGaD
Lenalidomide—ABCB1—Allograft Rejection—CD40—rheumatoid arthritis	5.57e-05	0.000798	CbGpPWpGaD
Lenalidomide—PTGS2—Selenium Micronutrient Network—SOD2—rheumatoid arthritis	5.55e-05	0.000795	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—TRAF6—rheumatoid arthritis	5.51e-05	0.000789	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—SH2B3—rheumatoid arthritis	5.51e-05	0.000789	CbGpPWpGaD
Lenalidomide—ABCB1—Allograft Rejection—CTLA4—rheumatoid arthritis	5.49e-05	0.000787	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—GZMB—rheumatoid arthritis	5.48e-05	0.000785	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—CCL3—rheumatoid arthritis	5.32e-05	0.000762	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—CXCL2—rheumatoid arthritis	5.32e-05	0.000762	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—SAA1—rheumatoid arthritis	5.2e-05	0.000745	CbGpPWpGaD
Lenalidomide—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IFNG—rheumatoid arthritis	5.11e-05	0.000732	CbGpPWpGaD
Lenalidomide—PTGS2—Spinal Cord Injury—CXCL10—rheumatoid arthritis	5.09e-05	0.00073	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—NCF1—rheumatoid arthritis	5.09e-05	0.000729	CbGpPWpGaD
Lenalidomide—ABCB1—Allograft Rejection—STAT1—rheumatoid arthritis	5.05e-05	0.000724	CbGpPWpGaD
Lenalidomide—PTGS2—Defective AMN causes hereditary megaloblastic anemia 1—MTHFR—rheumatoid arthritis	4.93e-05	0.000706	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—CD28—rheumatoid arthritis	4.9e-05	0.000701	CbGpPWpGaD
Lenalidomide—PTGS2—Selenium Micronutrient Network—MTHFR—rheumatoid arthritis	4.88e-05	0.0007	CbGpPWpGaD
Lenalidomide—ABCB1—Allograft Rejection—HLA-DQA1—rheumatoid arthritis	4.83e-05	0.000692	CbGpPWpGaD
Lenalidomide—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—CXCL8—rheumatoid arthritis	4.75e-05	0.00068	CbGpPWpGaD
Lenalidomide—PTGS2—Selenium Micronutrient Network—CRP—rheumatoid arthritis	4.64e-05	0.000665	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—UBE2D1—rheumatoid arthritis	4.61e-05	0.00066	CbGpPWpGaD
Lenalidomide—PTGS2—Aryl Hydrocarbon Receptor—NFKB1—rheumatoid arthritis	4.54e-05	0.000651	CbGpPWpGaD
Lenalidomide—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—IL2—rheumatoid arthritis	4.54e-05	0.00065	CbGpPWpGaD
Lenalidomide—ABCB1—Allograft Rejection—HLA-DQB1—rheumatoid arthritis	4.52e-05	0.000648	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—CXCL12—rheumatoid arthritis	4.52e-05	0.000648	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—BDKRB2—rheumatoid arthritis	4.52e-05	0.000648	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—ADRBK1—rheumatoid arthritis	4.47e-05	0.00064	CbGpPWpGaD
Lenalidomide—PTGS2—Spinal Cord Injury—IL1A—rheumatoid arthritis	4.39e-05	0.00063	CbGpPWpGaD
Lenalidomide—ABCB1—Allograft Rejection—IL1A—rheumatoid arthritis	4.29e-05	0.000615	CbGpPWpGaD
Lenalidomide—PTGS2—Selenium Micronutrient Network—ICAM1—rheumatoid arthritis	4.27e-05	0.000612	CbGpPWpGaD
Lenalidomide—ABCB1—Allograft Rejection—CD40LG—rheumatoid arthritis	4.27e-05	0.000612	CbGpPWpGaD
Lenalidomide—ABCB1—Allograft Rejection—IL10—rheumatoid arthritis	4.27e-05	0.000612	CbGpPWpGaD
Lenalidomide—PTGS2—Spinal Cord Injury—IL4—rheumatoid arthritis	4.25e-05	0.000609	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—RASGRP1—rheumatoid arthritis	4.22e-05	0.000604	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—SYK—rheumatoid arthritis	4.2e-05	0.000602	CbGpPWpGaD
Lenalidomide—ABCB1—Allograft Rejection—IL4—rheumatoid arthritis	4.15e-05	0.000595	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—PRKCQ—rheumatoid arthritis	4.12e-05	0.000591	CbGpPWpGaD
Lenalidomide—PTGS2—Aryl Hydrocarbon Receptor—VEGFA—rheumatoid arthritis	4.12e-05	0.000591	CbGpPWpGaD
Lenalidomide—ABCB1—Allograft Rejection—HLA-B—rheumatoid arthritis	4.06e-05	0.000582	CbGpPWpGaD
Lenalidomide—ABCB1—HIF-1-alpha transcription factor network—LEP—rheumatoid arthritis	4.06e-05	0.000581	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—STAT1—rheumatoid arthritis	4.05e-05	0.000581	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism of lipids and lipoproteins—PLD4—rheumatoid arthritis	4.04e-05	0.000578	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—CXCL10—rheumatoid arthritis	3.99e-05	0.000572	CbGpPWpGaD
Lenalidomide—ABCB1—Allograft Rejection—FASLG—rheumatoid arthritis	3.97e-05	0.000569	CbGpPWpGaD
Lenalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—TNFRSF1A—rheumatoid arthritis	3.88e-05	0.000556	CbGpPWpGaD
Lenalidomide—PTGS2—Signaling mediated by p38-alpha and p38-beta—TP53—rheumatoid arthritis	3.88e-05	0.000555	CbGpPWpGaD
Lenalidomide—ABCB1—Allograft Rejection—FAS—rheumatoid arthritis	3.83e-05	0.000548	CbGpPWpGaD
Lenalidomide—PTGS2—Selenium Micronutrient Network—CCL2—rheumatoid arthritis	3.82e-05	0.000547	CbGpPWpGaD
Lenalidomide—ABCB1—Allograft Rejection—IL2RA—rheumatoid arthritis	3.8e-05	0.000545	CbGpPWpGaD
Lenalidomide—ABCB1—HIF-1-alpha transcription factor network—NOS2—rheumatoid arthritis	3.78e-05	0.000541	CbGpPWpGaD
Lenalidomide—ABCB1—Allograft Rejection—C3—rheumatoid arthritis	3.77e-05	0.000541	CbGpPWpGaD
Lenalidomide—ABCB1—Allograft Rejection—HLA-A—rheumatoid arthritis	3.76e-05	0.000539	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—MMP3—rheumatoid arthritis	3.64e-05	0.000522	CbGpPWpGaD
Lenalidomide—PTGS2—Spinal Cord Injury—LEP—rheumatoid arthritis	3.59e-05	0.000515	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism of lipids and lipoproteins—PTGES—rheumatoid arthritis	3.57e-05	0.000511	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism of lipids and lipoproteins—GC—rheumatoid arthritis	3.57e-05	0.000511	CbGpPWpGaD
Lenalidomide—PTGS2—Selenium Micronutrient Network—ALB—rheumatoid arthritis	3.56e-05	0.00051	CbGpPWpGaD
Lenalidomide—PTGS2—Aryl Hydrocarbon Receptor—TNF—rheumatoid arthritis	3.53e-05	0.000506	CbGpPWpGaD
Lenalidomide—PTGS2—Spinal Cord Injury—TLR4—rheumatoid arthritis	3.52e-05	0.000505	CbGpPWpGaD
Lenalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—STAT1—rheumatoid arthritis	3.52e-05	0.000504	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—PTK2—rheumatoid arthritis	3.51e-05	0.000503	CbGpPWpGaD
Lenalidomide—ABCB1—Transmembrane transport of small molecules—LCN2—rheumatoid arthritis	3.47e-05	0.000497	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—CCL5—rheumatoid arthritis	3.44e-05	0.000493	CbGpPWpGaD
Lenalidomide—ABCB1—Allograft Rejection—HLA-DRB1—rheumatoid arthritis	3.44e-05	0.000492	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—CSF2—rheumatoid arthritis	3.39e-05	0.000485	CbGpPWpGaD
Lenalidomide—PTGS2—Spinal Cord Injury—ICAM1—rheumatoid arthritis	3.38e-05	0.000484	CbGpPWpGaD
Lenalidomide—PTGS2—Spinal Cord Injury—NOS2—rheumatoid arthritis	3.35e-05	0.00048	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism of lipids and lipoproteins—PLB1—rheumatoid arthritis	3.32e-05	0.000475	CbGpPWpGaD
Lenalidomide—PTGS2—Calcineurin-regulated NFAT-dependent transcription in lymphocytes—TNF—rheumatoid arthritis	3.3e-05	0.000474	CbGpPWpGaD
Lenalidomide—PTGS2—C-MYB transcription factor network—CD4—rheumatoid arthritis	3.26e-05	0.000467	CbGpPWpGaD
Lenalidomide—PTGS2—Selenium Micronutrient Network—IFNG—rheumatoid arthritis	3.25e-05	0.000465	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—SPP1—rheumatoid arthritis	3.18e-05	0.000456	CbGpPWpGaD
Lenalidomide—ABCB1—Allograft Rejection—CD80—rheumatoid arthritis	3.18e-05	0.000455	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—CCR5—rheumatoid arthritis	3.1e-05	0.000444	CbGpPWpGaD
Lenalidomide—Hypotension—Methylprednisolone—rheumatoid arthritis	3.07e-05	0.000241	CcSEcCtD
Lenalidomide—Pain—Prednisolone—rheumatoid arthritis	3.06e-05	0.00024	CcSEcCtD
Lenalidomide—Hepatitis—Methotrexate—rheumatoid arthritis	3.06e-05	0.00024	CcSEcCtD
Lenalidomide—Haemorrhage—Methotrexate—rheumatoid arthritis	3.06e-05	0.00024	CcSEcCtD
Lenalidomide—CDH5—Signaling Pathways—IL2RA—rheumatoid arthritis	3.05e-05	0.000437	CbGpPWpGaD
Lenalidomide—Decreased appetite—Hydrocortisone—rheumatoid arthritis	3.04e-05	0.000238	CcSEcCtD
Lenalidomide—Pharyngitis—Methotrexate—rheumatoid arthritis	3.04e-05	0.000238	CcSEcCtD
Lenalidomide—Nausea—Leflunomide—rheumatoid arthritis	3.03e-05	0.000237	CcSEcCtD
Lenalidomide—CDH5—Signaling Pathways—C3—rheumatoid arthritis	3.03e-05	0.000434	CbGpPWpGaD
Lenalidomide—Urinary tract disorder—Methotrexate—rheumatoid arthritis	3.02e-05	0.000237	CcSEcCtD
Lenalidomide—PTGS2—Spinal Cord Injury—CCL2—rheumatoid arthritis	3.02e-05	0.000433	CbGpPWpGaD
Lenalidomide—Gastrointestinal disorder—Hydrocortisone—rheumatoid arthritis	3.02e-05	0.000237	CcSEcCtD
Lenalidomide—Fatigue—Hydrocortisone—rheumatoid arthritis	3.01e-05	0.000236	CcSEcCtD
Lenalidomide—Vision blurred—Prednisone—rheumatoid arthritis	3e-05	0.000235	CcSEcCtD
Lenalidomide—Urethral disorder—Methotrexate—rheumatoid arthritis	3e-05	0.000235	CcSEcCtD
Lenalidomide—Musculoskeletal discomfort—Triamcinolone—rheumatoid arthritis	3e-05	0.000235	CcSEcCtD
Lenalidomide—Musculoskeletal discomfort—Methylprednisolone—rheumatoid arthritis	2.99e-05	0.000235	CcSEcCtD
Lenalidomide—Pain—Hydrocortisone—rheumatoid arthritis	2.99e-05	0.000234	CcSEcCtD
Lenalidomide—Oedema—Dexamethasone—rheumatoid arthritis	2.99e-05	0.000234	CcSEcCtD
Lenalidomide—Oedema—Betamethasone—rheumatoid arthritis	2.99e-05	0.000234	CcSEcCtD
Lenalidomide—Insomnia—Triamcinolone—rheumatoid arthritis	2.98e-05	0.000233	CcSEcCtD
Lenalidomide—Insomnia—Methylprednisolone—rheumatoid arthritis	2.97e-05	0.000233	CcSEcCtD
Lenalidomide—Infection—Betamethasone—rheumatoid arthritis	2.97e-05	0.000233	CcSEcCtD
Lenalidomide—Infection—Dexamethasone—rheumatoid arthritis	2.97e-05	0.000233	CcSEcCtD
Lenalidomide—Ill-defined disorder—Prednisone—rheumatoid arthritis	2.96e-05	0.000232	CcSEcCtD
Lenalidomide—Paraesthesia—Triamcinolone—rheumatoid arthritis	2.96e-05	0.000232	CcSEcCtD
Lenalidomide—Feeling abnormal—Prednisolone—rheumatoid arthritis	2.95e-05	0.000231	CcSEcCtD
Lenalidomide—Paraesthesia—Methylprednisolone—rheumatoid arthritis	2.95e-05	0.000231	CcSEcCtD
Lenalidomide—Visual impairment—Methotrexate—rheumatoid arthritis	2.95e-05	0.000231	CcSEcCtD
Lenalidomide—Anaemia—Prednisone—rheumatoid arthritis	2.95e-05	0.000231	CcSEcCtD
Lenalidomide—Shock—Dexamethasone—rheumatoid arthritis	2.94e-05	0.00023	CcSEcCtD
Lenalidomide—Shock—Betamethasone—rheumatoid arthritis	2.94e-05	0.00023	CcSEcCtD
Lenalidomide—Dyspnoea—Triamcinolone—rheumatoid arthritis	2.94e-05	0.00023	CcSEcCtD
Lenalidomide—Nervous system disorder—Betamethasone—rheumatoid arthritis	2.93e-05	0.00023	CcSEcCtD
Lenalidomide—Nervous system disorder—Dexamethasone—rheumatoid arthritis	2.93e-05	0.00023	CcSEcCtD
Lenalidomide—Agitation—Prednisone—rheumatoid arthritis	2.93e-05	0.00023	CcSEcCtD
Lenalidomide—Thrombocytopenia—Dexamethasone—rheumatoid arthritis	2.93e-05	0.000229	CcSEcCtD
Lenalidomide—Thrombocytopenia—Betamethasone—rheumatoid arthritis	2.93e-05	0.000229	CcSEcCtD
Lenalidomide—Tachycardia—Dexamethasone—rheumatoid arthritis	2.92e-05	0.000228	CcSEcCtD
Lenalidomide—Tachycardia—Betamethasone—rheumatoid arthritis	2.92e-05	0.000228	CcSEcCtD
Lenalidomide—Angioedema—Prednisone—rheumatoid arthritis	2.91e-05	0.000228	CcSEcCtD
Lenalidomide—PTGS2—Metabolism of lipids and lipoproteins—MED1—rheumatoid arthritis	2.91e-05	0.000417	CbGpPWpGaD
Lenalidomide—Hypersensitivity—Cyclosporine—rheumatoid arthritis	2.9e-05	0.000227	CcSEcCtD
Lenalidomide—Dyspepsia—Triamcinolone—rheumatoid arthritis	2.9e-05	0.000227	CcSEcCtD
Lenalidomide—PTGS2—Selenium Micronutrient Network—IL1B—rheumatoid arthritis	2.9e-05	0.000415	CbGpPWpGaD
Lenalidomide—Erythema multiforme—Methotrexate—rheumatoid arthritis	2.89e-05	0.000227	CcSEcCtD
Lenalidomide—Dyspepsia—Methylprednisolone—rheumatoid arthritis	2.89e-05	0.000227	CcSEcCtD
Lenalidomide—Hyperhidrosis—Betamethasone—rheumatoid arthritis	2.89e-05	0.000226	CcSEcCtD
Lenalidomide—Hyperhidrosis—Dexamethasone—rheumatoid arthritis	2.89e-05	0.000226	CcSEcCtD
Lenalidomide—Feeling abnormal—Hydrocortisone—rheumatoid arthritis	2.88e-05	0.000226	CcSEcCtD
Lenalidomide—Malaise—Prednisone—rheumatoid arthritis	2.87e-05	0.000225	CcSEcCtD
Lenalidomide—Vertigo—Prednisone—rheumatoid arthritis	2.86e-05	0.000224	CcSEcCtD
Lenalidomide—Eye disorder—Methotrexate—rheumatoid arthritis	2.86e-05	0.000224	CcSEcCtD
Lenalidomide—Gastrointestinal pain—Hydrocortisone—rheumatoid arthritis	2.86e-05	0.000224	CcSEcCtD
Lenalidomide—Syncope—Prednisone—rheumatoid arthritis	2.86e-05	0.000224	CcSEcCtD
Lenalidomide—Tinnitus—Methotrexate—rheumatoid arthritis	2.85e-05	0.000224	CcSEcCtD
Lenalidomide—Anorexia—Betamethasone—rheumatoid arthritis	2.85e-05	0.000223	CcSEcCtD
Lenalidomide—Anorexia—Dexamethasone—rheumatoid arthritis	2.85e-05	0.000223	CcSEcCtD
Lenalidomide—Urticaria—Prednisolone—rheumatoid arthritis	2.84e-05	0.000223	CcSEcCtD
Lenalidomide—Cardiac disorder—Methotrexate—rheumatoid arthritis	2.84e-05	0.000223	CcSEcCtD
Lenalidomide—Fatigue—Triamcinolone—rheumatoid arthritis	2.84e-05	0.000222	CcSEcCtD
Lenalidomide—Fatigue—Methylprednisolone—rheumatoid arthritis	2.83e-05	0.000222	CcSEcCtD
Lenalidomide—Asthenia—Cyclosporine—rheumatoid arthritis	2.82e-05	0.000221	CcSEcCtD
Lenalidomide—CDH5—Signaling Pathways—LEP—rheumatoid arthritis	2.82e-05	0.000404	CbGpPWpGaD
Lenalidomide—Pain—Triamcinolone—rheumatoid arthritis	2.82e-05	0.000221	CcSEcCtD
Lenalidomide—Loss of consciousness—Prednisone—rheumatoid arthritis	2.8e-05	0.00022	CcSEcCtD
Lenalidomide—Hypotension—Dexamethasone—rheumatoid arthritis	2.79e-05	0.000219	CcSEcCtD
Lenalidomide—Hypotension—Betamethasone—rheumatoid arthritis	2.79e-05	0.000219	CcSEcCtD
Lenalidomide—Pruritus—Cyclosporine—rheumatoid arthritis	2.78e-05	0.000218	CcSEcCtD
Lenalidomide—Urticaria—Hydrocortisone—rheumatoid arthritis	2.78e-05	0.000218	CcSEcCtD
Lenalidomide—Angiopathy—Methotrexate—rheumatoid arthritis	2.78e-05	0.000218	CcSEcCtD
Lenalidomide—Immune system disorder—Methotrexate—rheumatoid arthritis	2.76e-05	0.000217	CcSEcCtD
Lenalidomide—Body temperature increased—Hydrocortisone—rheumatoid arthritis	2.76e-05	0.000217	CcSEcCtD
Lenalidomide—Abdominal pain—Hydrocortisone—rheumatoid arthritis	2.76e-05	0.000217	CcSEcCtD
Lenalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—FASLG—rheumatoid arthritis	2.76e-05	0.000396	CbGpPWpGaD
Lenalidomide—Mediastinal disorder—Methotrexate—rheumatoid arthritis	2.76e-05	0.000216	CcSEcCtD
Lenalidomide—Hypertension—Prednisone—rheumatoid arthritis	2.75e-05	0.000216	CcSEcCtD
Lenalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—TNFRSF1A—rheumatoid arthritis	2.75e-05	0.000394	CbGpPWpGaD
Lenalidomide—Chills—Methotrexate—rheumatoid arthritis	2.75e-05	0.000215	CcSEcCtD
Lenalidomide—Musculoskeletal discomfort—Betamethasone—rheumatoid arthritis	2.72e-05	0.000213	CcSEcCtD
Lenalidomide—Musculoskeletal discomfort—Dexamethasone—rheumatoid arthritis	2.72e-05	0.000213	CcSEcCtD
Lenalidomide—Myalgia—Prednisone—rheumatoid arthritis	2.71e-05	0.000213	CcSEcCtD
Lenalidomide—Arthralgia—Prednisone—rheumatoid arthritis	2.71e-05	0.000213	CcSEcCtD
Lenalidomide—Feeling abnormal—Triamcinolone—rheumatoid arthritis	2.71e-05	0.000213	CcSEcCtD
Lenalidomide—Feeling abnormal—Methylprednisolone—rheumatoid arthritis	2.71e-05	0.000212	CcSEcCtD
Lenalidomide—Anxiety—Prednisone—rheumatoid arthritis	2.7e-05	0.000212	CcSEcCtD
Lenalidomide—Alopecia—Methotrexate—rheumatoid arthritis	2.7e-05	0.000212	CcSEcCtD
Lenalidomide—PTGS2—Selenium Micronutrient Network—NFKB1—rheumatoid arthritis	2.7e-05	0.000387	CbGpPWpGaD
Lenalidomide—Insomnia—Dexamethasone—rheumatoid arthritis	2.7e-05	0.000212	CcSEcCtD
Lenalidomide—Insomnia—Betamethasone—rheumatoid arthritis	2.7e-05	0.000212	CcSEcCtD
Lenalidomide—Unspecified disorder of skin and subcutaneous tissue—Prednisone—rheumatoid arthritis	2.7e-05	0.000211	CcSEcCtD
Lenalidomide—PTGS2—Metabolism—FADS2—rheumatoid arthritis	2.69e-05	0.000386	CbGpPWpGaD
Lenalidomide—Diarrhoea—Cyclosporine—rheumatoid arthritis	2.69e-05	0.000211	CcSEcCtD
Lenalidomide—Gastrointestinal pain—Methylprednisolone—rheumatoid arthritis	2.69e-05	0.00021	CcSEcCtD
Lenalidomide—Paraesthesia—Betamethasone—rheumatoid arthritis	2.68e-05	0.00021	CcSEcCtD
Lenalidomide—Paraesthesia—Dexamethasone—rheumatoid arthritis	2.68e-05	0.00021	CcSEcCtD
Lenalidomide—Discomfort—Prednisone—rheumatoid arthritis	2.68e-05	0.00021	CcSEcCtD
Lenalidomide—Mental disorder—Methotrexate—rheumatoid arthritis	2.68e-05	0.00021	CcSEcCtD
Lenalidomide—Malnutrition—Methotrexate—rheumatoid arthritis	2.66e-05	0.000209	CcSEcCtD
Lenalidomide—Erythema—Methotrexate—rheumatoid arthritis	2.66e-05	0.000209	CcSEcCtD
Lenalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—FAS—rheumatoid arthritis	2.66e-05	0.000382	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—FN1—rheumatoid arthritis	2.66e-05	0.000381	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—IL6ST—rheumatoid arthritis	2.65e-05	0.000379	CbGpPWpGaD
Lenalidomide—Hypersensitivity—Prednisolone—rheumatoid arthritis	2.64e-05	0.000207	CcSEcCtD
Lenalidomide—Dyspepsia—Betamethasone—rheumatoid arthritis	2.63e-05	0.000206	CcSEcCtD
Lenalidomide—Dyspepsia—Dexamethasone—rheumatoid arthritis	2.63e-05	0.000206	CcSEcCtD
Lenalidomide—Urticaria—Triamcinolone—rheumatoid arthritis	2.62e-05	0.000205	CcSEcCtD
Lenalidomide—Urticaria—Methylprednisolone—rheumatoid arthritis	2.61e-05	0.000204	CcSEcCtD
Lenalidomide—Dysgeusia—Methotrexate—rheumatoid arthritis	2.61e-05	0.000204	CcSEcCtD
Lenalidomide—Body temperature increased—Triamcinolone—rheumatoid arthritis	2.6e-05	0.000204	CcSEcCtD
Lenalidomide—Dizziness—Cyclosporine—rheumatoid arthritis	2.6e-05	0.000204	CcSEcCtD
Lenalidomide—Oedema—Prednisone—rheumatoid arthritis	2.6e-05	0.000204	CcSEcCtD
Lenalidomide—Abdominal pain—Methylprednisolone—rheumatoid arthritis	2.6e-05	0.000203	CcSEcCtD
Lenalidomide—Decreased appetite—Dexamethasone—rheumatoid arthritis	2.6e-05	0.000203	CcSEcCtD
Lenalidomide—Decreased appetite—Betamethasone—rheumatoid arthritis	2.6e-05	0.000203	CcSEcCtD
Lenalidomide—Infection—Prednisone—rheumatoid arthritis	2.58e-05	0.000203	CcSEcCtD
Lenalidomide—Gastrointestinal disorder—Betamethasone—rheumatoid arthritis	2.58e-05	0.000202	CcSEcCtD
Lenalidomide—Gastrointestinal disorder—Dexamethasone—rheumatoid arthritis	2.58e-05	0.000202	CcSEcCtD
Lenalidomide—Back pain—Methotrexate—rheumatoid arthritis	2.58e-05	0.000202	CcSEcCtD
Lenalidomide—Hypersensitivity—Hydrocortisone—rheumatoid arthritis	2.58e-05	0.000202	CcSEcCtD
Lenalidomide—Fatigue—Dexamethasone—rheumatoid arthritis	2.58e-05	0.000202	CcSEcCtD
Lenalidomide—Fatigue—Betamethasone—rheumatoid arthritis	2.58e-05	0.000202	CcSEcCtD
Lenalidomide—PTGS2—Spinal Cord Injury—IFNG—rheumatoid arthritis	2.57e-05	0.000368	CbGpPWpGaD
Lenalidomide—Shock—Prednisone—rheumatoid arthritis	2.56e-05	0.000201	CcSEcCtD
Lenalidomide—Pain—Betamethasone—rheumatoid arthritis	2.55e-05	0.0002	CcSEcCtD
Lenalidomide—Pain—Dexamethasone—rheumatoid arthritis	2.55e-05	0.0002	CcSEcCtD
Lenalidomide—Nervous system disorder—Prednisone—rheumatoid arthritis	2.55e-05	0.0002	CcSEcCtD
Lenalidomide—CDH5—Signaling Pathways—CD80—rheumatoid arthritis	2.55e-05	0.000365	CbGpPWpGaD
Lenalidomide—Tachycardia—Prednisone—rheumatoid arthritis	2.54e-05	0.000199	CcSEcCtD
Lenalidomide—Skin disorder—Prednisone—rheumatoid arthritis	2.53e-05	0.000198	CcSEcCtD
Lenalidomide—Hyperhidrosis—Prednisone—rheumatoid arthritis	2.52e-05	0.000197	CcSEcCtD
Lenalidomide—Vision blurred—Methotrexate—rheumatoid arthritis	2.51e-05	0.000197	CcSEcCtD
Lenalidomide—ABCB1—Allograft Rejection—IFNG—rheumatoid arthritis	2.51e-05	0.00036	CbGpPWpGaD
Lenalidomide—Asthenia—Hydrocortisone—rheumatoid arthritis	2.51e-05	0.000197	CcSEcCtD
Lenalidomide—Vomiting—Cyclosporine—rheumatoid arthritis	2.5e-05	0.000196	CcSEcCtD
Lenalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—STAT1—rheumatoid arthritis	2.49e-05	0.000357	CbGpPWpGaD
Lenalidomide—Rash—Cyclosporine—rheumatoid arthritis	2.48e-05	0.000194	CcSEcCtD
Lenalidomide—Anorexia—Prednisone—rheumatoid arthritis	2.48e-05	0.000194	CcSEcCtD
Lenalidomide—Dermatitis—Cyclosporine—rheumatoid arthritis	2.48e-05	0.000194	CcSEcCtD
Lenalidomide—Pruritus—Hydrocortisone—rheumatoid arthritis	2.47e-05	0.000194	CcSEcCtD
Lenalidomide—Ill-defined disorder—Methotrexate—rheumatoid arthritis	2.47e-05	0.000194	CcSEcCtD
Lenalidomide—Headache—Cyclosporine—rheumatoid arthritis	2.47e-05	0.000193	CcSEcCtD
Lenalidomide—Anaemia—Methotrexate—rheumatoid arthritis	2.46e-05	0.000193	CcSEcCtD
Lenalidomide—Feeling abnormal—Betamethasone—rheumatoid arthritis	2.46e-05	0.000193	CcSEcCtD
Lenalidomide—Feeling abnormal—Dexamethasone—rheumatoid arthritis	2.46e-05	0.000193	CcSEcCtD
Lenalidomide—Gastrointestinal pain—Betamethasone—rheumatoid arthritis	2.44e-05	0.000191	CcSEcCtD
Lenalidomide—Gastrointestinal pain—Dexamethasone—rheumatoid arthritis	2.44e-05	0.000191	CcSEcCtD
Lenalidomide—Hypersensitivity—Triamcinolone—rheumatoid arthritis	2.43e-05	0.00019	CcSEcCtD
Lenalidomide—CDH5—Signaling Pathways—POMC—rheumatoid arthritis	2.42e-05	0.000347	CbGpPWpGaD
Lenalidomide—Hypersensitivity—Methylprednisolone—rheumatoid arthritis	2.42e-05	0.00019	CcSEcCtD
Lenalidomide—ABCB1—Transmembrane transport of small molecules—SLC22A4—rheumatoid arthritis	2.4e-05	0.000344	CbGpPWpGaD
Lenalidomide—Malaise—Methotrexate—rheumatoid arthritis	2.4e-05	0.000188	CcSEcCtD
Lenalidomide—Vertigo—Methotrexate—rheumatoid arthritis	2.39e-05	0.000188	CcSEcCtD
Lenalidomide—Diarrhoea—Hydrocortisone—rheumatoid arthritis	2.39e-05	0.000187	CcSEcCtD
Lenalidomide—PTGS2—Spinal Cord Injury—CXCL8—rheumatoid arthritis	2.39e-05	0.000342	CbGpPWpGaD
Lenalidomide—Leukopenia—Methotrexate—rheumatoid arthritis	2.38e-05	0.000187	CcSEcCtD
Lenalidomide—Urticaria—Betamethasone—rheumatoid arthritis	2.37e-05	0.000186	CcSEcCtD
Lenalidomide—Urticaria—Dexamethasone—rheumatoid arthritis	2.37e-05	0.000186	CcSEcCtD
Lenalidomide—Musculoskeletal discomfort—Prednisone—rheumatoid arthritis	2.37e-05	0.000186	CcSEcCtD
Lenalidomide—CDH5—Signaling Pathways—CCL2—rheumatoid arthritis	2.37e-05	0.000339	CbGpPWpGaD
Lenalidomide—Dizziness—Prednisolone—rheumatoid arthritis	2.37e-05	0.000186	CcSEcCtD
Lenalidomide—Asthenia—Triamcinolone—rheumatoid arthritis	2.36e-05	0.000185	CcSEcCtD
Lenalidomide—Abdominal pain—Dexamethasone—rheumatoid arthritis	2.36e-05	0.000185	CcSEcCtD
Lenalidomide—Abdominal pain—Betamethasone—rheumatoid arthritis	2.36e-05	0.000185	CcSEcCtD
Lenalidomide—Body temperature increased—Dexamethasone—rheumatoid arthritis	2.36e-05	0.000185	CcSEcCtD
Lenalidomide—Body temperature increased—Betamethasone—rheumatoid arthritis	2.36e-05	0.000185	CcSEcCtD
Lenalidomide—CDH5—Signaling Pathways—IL6R—rheumatoid arthritis	2.36e-05	0.000338	CbGpPWpGaD
Lenalidomide—Asthenia—Methylprednisolone—rheumatoid arthritis	2.36e-05	0.000185	CcSEcCtD
Lenalidomide—Insomnia—Prednisone—rheumatoid arthritis	2.35e-05	0.000184	CcSEcCtD
Lenalidomide—Nausea—Cyclosporine—rheumatoid arthritis	2.34e-05	0.000183	CcSEcCtD
Lenalidomide—Paraesthesia—Prednisone—rheumatoid arthritis	2.34e-05	0.000183	CcSEcCtD
Lenalidomide—ABCB1—Allograft Rejection—CXCL8—rheumatoid arthritis	2.33e-05	0.000334	CbGpPWpGaD
Lenalidomide—Pruritus—Triamcinolone—rheumatoid arthritis	2.33e-05	0.000183	CcSEcCtD
Lenalidomide—PTGS2—Disease—SYVN1—rheumatoid arthritis	2.33e-05	0.000333	CbGpPWpGaD
Lenalidomide—Cough—Methotrexate—rheumatoid arthritis	2.32e-05	0.000182	CcSEcCtD
Lenalidomide—Pruritus—Methylprednisolone—rheumatoid arthritis	2.32e-05	0.000182	CcSEcCtD
Lenalidomide—Dizziness—Hydrocortisone—rheumatoid arthritis	2.31e-05	0.000181	CcSEcCtD
Lenalidomide—PTGS2—Spinal Cord Injury—IL1B—rheumatoid arthritis	2.29e-05	0.000328	CbGpPWpGaD
Lenalidomide—Dyspepsia—Prednisone—rheumatoid arthritis	2.29e-05	0.000179	CcSEcCtD
Lenalidomide—PTGS2—Spinal Cord Injury—IL2—rheumatoid arthritis	2.28e-05	0.000327	CbGpPWpGaD
Lenalidomide—Chest pain—Methotrexate—rheumatoid arthritis	2.27e-05	0.000178	CcSEcCtD
Lenalidomide—Arthralgia—Methotrexate—rheumatoid arthritis	2.27e-05	0.000178	CcSEcCtD
Lenalidomide—Myalgia—Methotrexate—rheumatoid arthritis	2.27e-05	0.000178	CcSEcCtD
Lenalidomide—Decreased appetite—Prednisone—rheumatoid arthritis	2.26e-05	0.000177	CcSEcCtD
Lenalidomide—Rash—Prednisolone—rheumatoid arthritis	2.26e-05	0.000177	CcSEcCtD
Lenalidomide—Dermatitis—Prednisolone—rheumatoid arthritis	2.26e-05	0.000177	CcSEcCtD
Lenalidomide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—rheumatoid arthritis	2.25e-05	0.000176	CcSEcCtD
Lenalidomide—Diarrhoea—Methylprednisolone—rheumatoid arthritis	2.25e-05	0.000176	CcSEcCtD
Lenalidomide—Fatigue—Prednisone—rheumatoid arthritis	2.24e-05	0.000176	CcSEcCtD
Lenalidomide—Headache—Prednisolone—rheumatoid arthritis	2.24e-05	0.000176	CcSEcCtD
Lenalidomide—Discomfort—Methotrexate—rheumatoid arthritis	2.24e-05	0.000176	CcSEcCtD
Lenalidomide—PTGS2—Metabolism of lipids and lipoproteins—ALOX5—rheumatoid arthritis	2.24e-05	0.000321	CbGpPWpGaD
Lenalidomide—ABCB1—Allograft Rejection—IL1B—rheumatoid arthritis	2.24e-05	0.000321	CbGpPWpGaD
Lenalidomide—ABCB1—Allograft Rejection—IL2—rheumatoid arthritis	2.23e-05	0.00032	CbGpPWpGaD
Lenalidomide—Constipation—Prednisone—rheumatoid arthritis	2.23e-05	0.000174	CcSEcCtD
Lenalidomide—Vomiting—Hydrocortisone—rheumatoid arthritis	2.22e-05	0.000174	CcSEcCtD
Lenalidomide—Rash—Hydrocortisone—rheumatoid arthritis	2.2e-05	0.000173	CcSEcCtD
Lenalidomide—Dermatitis—Hydrocortisone—rheumatoid arthritis	2.2e-05	0.000173	CcSEcCtD
Lenalidomide—Confusional state—Methotrexate—rheumatoid arthritis	2.19e-05	0.000172	CcSEcCtD
Lenalidomide—Headache—Hydrocortisone—rheumatoid arthritis	2.19e-05	0.000172	CcSEcCtD
Lenalidomide—ABCB1—HIF-1-alpha transcription factor network—VEGFA—rheumatoid arthritis	2.19e-05	0.000314	CbGpPWpGaD
Lenalidomide—Dizziness—Triamcinolone—rheumatoid arthritis	2.18e-05	0.000171	CcSEcCtD
Lenalidomide—Dizziness—Methylprednisolone—rheumatoid arthritis	2.17e-05	0.00017	CcSEcCtD
Lenalidomide—PTGS2—Spinal Cord Injury—MMP9—rheumatoid arthritis	2.16e-05	0.00031	CbGpPWpGaD
Lenalidomide—Infection—Methotrexate—rheumatoid arthritis	2.16e-05	0.000169	CcSEcCtD
Lenalidomide—CDH5—Signaling Pathways—TYK2—rheumatoid arthritis	2.15e-05	0.000308	CbGpPWpGaD
Lenalidomide—Feeling abnormal—Prednisone—rheumatoid arthritis	2.14e-05	0.000168	CcSEcCtD
Lenalidomide—Asthenia—Dexamethasone—rheumatoid arthritis	2.14e-05	0.000168	CcSEcCtD
Lenalidomide—Asthenia—Betamethasone—rheumatoid arthritis	2.14e-05	0.000168	CcSEcCtD
Lenalidomide—Nervous system disorder—Methotrexate—rheumatoid arthritis	2.13e-05	0.000167	CcSEcCtD
Lenalidomide—Thrombocytopenia—Methotrexate—rheumatoid arthritis	2.13e-05	0.000167	CcSEcCtD
Lenalidomide—Gastrointestinal pain—Prednisone—rheumatoid arthritis	2.13e-05	0.000167	CcSEcCtD
Lenalidomide—Nausea—Prednisolone—rheumatoid arthritis	2.13e-05	0.000167	CcSEcCtD
Lenalidomide—Pruritus—Betamethasone—rheumatoid arthritis	2.11e-05	0.000166	CcSEcCtD
Lenalidomide—Pruritus—Dexamethasone—rheumatoid arthritis	2.11e-05	0.000166	CcSEcCtD
Lenalidomide—Skin disorder—Methotrexate—rheumatoid arthritis	2.11e-05	0.000165	CcSEcCtD
Lenalidomide—CDH5—Signaling Pathways—NOS3—rheumatoid arthritis	2.11e-05	0.000303	CbGpPWpGaD
Lenalidomide—PTGS2—Selenium Micronutrient Network—TNF—rheumatoid arthritis	2.1e-05	0.000301	CbGpPWpGaD
Lenalidomide—Hyperhidrosis—Methotrexate—rheumatoid arthritis	2.1e-05	0.000165	CcSEcCtD
Lenalidomide—Vomiting—Triamcinolone—rheumatoid arthritis	2.09e-05	0.000164	CcSEcCtD
Lenalidomide—Vomiting—Methylprednisolone—rheumatoid arthritis	2.09e-05	0.000164	CcSEcCtD
Lenalidomide—Nausea—Hydrocortisone—rheumatoid arthritis	2.08e-05	0.000163	CcSEcCtD
Lenalidomide—Rash—Triamcinolone—rheumatoid arthritis	2.08e-05	0.000163	CcSEcCtD
Lenalidomide—Dermatitis—Triamcinolone—rheumatoid arthritis	2.07e-05	0.000163	CcSEcCtD
Lenalidomide—PTGS2—Disease—ACAN—rheumatoid arthritis	2.07e-05	0.000297	CbGpPWpGaD
Lenalidomide—Anorexia—Methotrexate—rheumatoid arthritis	2.07e-05	0.000162	CcSEcCtD
Lenalidomide—Rash—Methylprednisolone—rheumatoid arthritis	2.07e-05	0.000162	CcSEcCtD
Lenalidomide—Dermatitis—Methylprednisolone—rheumatoid arthritis	2.07e-05	0.000162	CcSEcCtD
Lenalidomide—Urticaria—Prednisone—rheumatoid arthritis	2.07e-05	0.000162	CcSEcCtD
Lenalidomide—Headache—Triamcinolone—rheumatoid arthritis	2.06e-05	0.000162	CcSEcCtD
Lenalidomide—Headache—Methylprednisolone—rheumatoid arthritis	2.06e-05	0.000161	CcSEcCtD
Lenalidomide—Abdominal pain—Prednisone—rheumatoid arthritis	2.06e-05	0.000161	CcSEcCtD
Lenalidomide—Body temperature increased—Prednisone—rheumatoid arthritis	2.06e-05	0.000161	CcSEcCtD
Lenalidomide—Diarrhoea—Dexamethasone—rheumatoid arthritis	2.04e-05	0.00016	CcSEcCtD
Lenalidomide—Diarrhoea—Betamethasone—rheumatoid arthritis	2.04e-05	0.00016	CcSEcCtD
Lenalidomide—Hypotension—Methotrexate—rheumatoid arthritis	2.03e-05	0.000159	CcSEcCtD
Lenalidomide—Musculoskeletal discomfort—Methotrexate—rheumatoid arthritis	1.98e-05	0.000155	CcSEcCtD
Lenalidomide—Dizziness—Betamethasone—rheumatoid arthritis	1.98e-05	0.000155	CcSEcCtD
Lenalidomide—Dizziness—Dexamethasone—rheumatoid arthritis	1.98e-05	0.000155	CcSEcCtD
Lenalidomide—Insomnia—Methotrexate—rheumatoid arthritis	1.97e-05	0.000154	CcSEcCtD
Lenalidomide—ABCB1—Transmembrane transport of small molecules—MED1—rheumatoid arthritis	1.96e-05	0.000281	CbGpPWpGaD
Lenalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—FASLG—rheumatoid arthritis	1.96e-05	0.000281	CbGpPWpGaD
Lenalidomide—Nausea—Triamcinolone—rheumatoid arthritis	1.96e-05	0.000153	CcSEcCtD
Lenalidomide—Paraesthesia—Methotrexate—rheumatoid arthritis	1.95e-05	0.000153	CcSEcCtD
Lenalidomide—Nausea—Methylprednisolone—rheumatoid arthritis	1.95e-05	0.000153	CcSEcCtD
Lenalidomide—PTGS2—Disease—SLC25A12—rheumatoid arthritis	1.95e-05	0.000279	CbGpPWpGaD
Lenalidomide—Dyspnoea—Methotrexate—rheumatoid arthritis	1.94e-05	0.000152	CcSEcCtD
Lenalidomide—Somnolence—Methotrexate—rheumatoid arthritis	1.93e-05	0.000151	CcSEcCtD
Lenalidomide—Hypersensitivity—Prednisone—rheumatoid arthritis	1.92e-05	0.00015	CcSEcCtD
Lenalidomide—Dyspepsia—Methotrexate—rheumatoid arthritis	1.91e-05	0.00015	CcSEcCtD
Lenalidomide—ABCB1—Metabolism—FADS2—rheumatoid arthritis	1.91e-05	0.000274	CbGpPWpGaD
Lenalidomide—Vomiting—Betamethasone—rheumatoid arthritis	1.9e-05	0.000149	CcSEcCtD
Lenalidomide—Vomiting—Dexamethasone—rheumatoid arthritis	1.9e-05	0.000149	CcSEcCtD
Lenalidomide—ABCB1—Allograft Rejection—VEGFA—rheumatoid arthritis	1.9e-05	0.000272	CbGpPWpGaD
Lenalidomide—Decreased appetite—Methotrexate—rheumatoid arthritis	1.89e-05	0.000148	CcSEcCtD
Lenalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—rheumatoid arthritis	1.89e-05	0.000271	CbGpPWpGaD
Lenalidomide—Rash—Dexamethasone—rheumatoid arthritis	1.88e-05	0.000148	CcSEcCtD
Lenalidomide—Rash—Betamethasone—rheumatoid arthritis	1.88e-05	0.000148	CcSEcCtD
Lenalidomide—Dermatitis—Betamethasone—rheumatoid arthritis	1.88e-05	0.000147	CcSEcCtD
Lenalidomide—Dermatitis—Dexamethasone—rheumatoid arthritis	1.88e-05	0.000147	CcSEcCtD
Lenalidomide—Gastrointestinal disorder—Methotrexate—rheumatoid arthritis	1.88e-05	0.000147	CcSEcCtD
Lenalidomide—Fatigue—Methotrexate—rheumatoid arthritis	1.87e-05	0.000147	CcSEcCtD
Lenalidomide—CDH5—Signaling Pathways—CXCL8—rheumatoid arthritis	1.87e-05	0.000268	CbGpPWpGaD
Lenalidomide—Headache—Dexamethasone—rheumatoid arthritis	1.87e-05	0.000147	CcSEcCtD
Lenalidomide—Headache—Betamethasone—rheumatoid arthritis	1.87e-05	0.000147	CcSEcCtD
Lenalidomide—Asthenia—Prednisone—rheumatoid arthritis	1.87e-05	0.000146	CcSEcCtD
Lenalidomide—Pain—Methotrexate—rheumatoid arthritis	1.86e-05	0.000146	CcSEcCtD
Lenalidomide—Pruritus—Prednisone—rheumatoid arthritis	1.84e-05	0.000144	CcSEcCtD
Lenalidomide—PTGS2—Metabolism—PLD4—rheumatoid arthritis	1.8e-05	0.000258	CbGpPWpGaD
Lenalidomide—Feeling abnormal—Methotrexate—rheumatoid arthritis	1.79e-05	0.00014	CcSEcCtD
Lenalidomide—CDH5—Signaling Pathways—IL2—rheumatoid arthritis	1.79e-05	0.000256	CbGpPWpGaD
Lenalidomide—PTGS2—Spinal Cord Injury—TGFB1—rheumatoid arthritis	1.78e-05	0.000255	CbGpPWpGaD
Lenalidomide—Diarrhoea—Prednisone—rheumatoid arthritis	1.78e-05	0.000139	CcSEcCtD
Lenalidomide—Gastrointestinal pain—Methotrexate—rheumatoid arthritis	1.78e-05	0.000139	CcSEcCtD
Lenalidomide—Nausea—Dexamethasone—rheumatoid arthritis	1.77e-05	0.000139	CcSEcCtD
Lenalidomide—Nausea—Betamethasone—rheumatoid arthritis	1.77e-05	0.000139	CcSEcCtD
Lenalidomide—PTGS2—Disease—PLB1—rheumatoid arthritis	1.76e-05	0.000253	CbGpPWpGaD
Lenalidomide—ABCB1—Allograft Rejection—TGFB1—rheumatoid arthritis	1.74e-05	0.000249	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—ACAN—rheumatoid arthritis	1.74e-05	0.000249	CbGpPWpGaD
Lenalidomide—Urticaria—Methotrexate—rheumatoid arthritis	1.73e-05	0.000135	CcSEcCtD
Lenalidomide—Dizziness—Prednisone—rheumatoid arthritis	1.72e-05	0.000135	CcSEcCtD
Lenalidomide—Body temperature increased—Methotrexate—rheumatoid arthritis	1.72e-05	0.000135	CcSEcCtD
Lenalidomide—Abdominal pain—Methotrexate—rheumatoid arthritis	1.72e-05	0.000135	CcSEcCtD
Lenalidomide—PTGS2—Selenium Micronutrient Network—IL6—rheumatoid arthritis	1.7e-05	0.000243	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—MMP9—rheumatoid arthritis	1.69e-05	0.000243	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—NFKB1—rheumatoid arthritis	1.68e-05	0.00024	CbGpPWpGaD
Lenalidomide—PTGS2—Spinal Cord Injury—TNF—rheumatoid arthritis	1.66e-05	0.000238	CbGpPWpGaD
Lenalidomide—Vomiting—Prednisone—rheumatoid arthritis	1.65e-05	0.00013	CcSEcCtD
Lenalidomide—CDH5—Signaling Pathways—MAPK8—rheumatoid arthritis	1.65e-05	0.000236	CbGpPWpGaD
Lenalidomide—Rash—Prednisone—rheumatoid arthritis	1.64e-05	0.000129	CcSEcCtD
Lenalidomide—Dermatitis—Prednisone—rheumatoid arthritis	1.64e-05	0.000128	CcSEcCtD
Lenalidomide—PTGS2—Metabolism—SLC25A12—rheumatoid arthritis	1.63e-05	0.000234	CbGpPWpGaD
Lenalidomide—Headache—Prednisone—rheumatoid arthritis	1.63e-05	0.000128	CcSEcCtD
Lenalidomide—PTGS2—Disease—RBPJ—rheumatoid arthritis	1.63e-05	0.000233	CbGpPWpGaD
Lenalidomide—ABCB1—Allograft Rejection—TNF—rheumatoid arthritis	1.62e-05	0.000233	CbGpPWpGaD
Lenalidomide—Hypersensitivity—Methotrexate—rheumatoid arthritis	1.6e-05	0.000126	CcSEcCtD
Lenalidomide—PTGS2—Metabolism—PTGES—rheumatoid arthritis	1.59e-05	0.000228	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—GC—rheumatoid arthritis	1.59e-05	0.000228	CbGpPWpGaD
Lenalidomide—Asthenia—Methotrexate—rheumatoid arthritis	1.56e-05	0.000122	CcSEcCtD
Lenalidomide—Nausea—Prednisone—rheumatoid arthritis	1.55e-05	0.000121	CcSEcCtD
Lenalidomide—Pruritus—Methotrexate—rheumatoid arthritis	1.54e-05	0.000121	CcSEcCtD
Lenalidomide—CDH5—Signaling Pathways—VEGFA—rheumatoid arthritis	1.52e-05	0.000218	CbGpPWpGaD
Lenalidomide—ABCB1—Transmembrane transport of small molecules—SLC11A1—rheumatoid arthritis	1.5e-05	0.000215	CbGpPWpGaD
Lenalidomide—Diarrhoea—Methotrexate—rheumatoid arthritis	1.49e-05	0.000117	CcSEcCtD
Lenalidomide—PTGS2—Metabolism—PLB1—rheumatoid arthritis	1.48e-05	0.000212	CbGpPWpGaD
Lenalidomide—PTGS2—Spinal Cord Injury—TP53—rheumatoid arthritis	1.47e-05	0.00021	CbGpPWpGaD
Lenalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—NFKB1—rheumatoid arthritis	1.45e-05	0.000208	CbGpPWpGaD
Lenalidomide—Dizziness—Methotrexate—rheumatoid arthritis	1.44e-05	0.000113	CcSEcCtD
Lenalidomide—PTGS2—Disease—B3GNT2—rheumatoid arthritis	1.44e-05	0.000206	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—ACP5—rheumatoid arthritis	1.44e-05	0.000206	CbGpPWpGaD
Lenalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK8—rheumatoid arthritis	1.43e-05	0.000205	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—TGFB1—rheumatoid arthritis	1.4e-05	0.0002	CbGpPWpGaD
Lenalidomide—Vomiting—Methotrexate—rheumatoid arthritis	1.38e-05	0.000108	CcSEcCtD
Lenalidomide—Rash—Methotrexate—rheumatoid arthritis	1.37e-05	0.000107	CcSEcCtD
Lenalidomide—Dermatitis—Methotrexate—rheumatoid arthritis	1.37e-05	0.000107	CcSEcCtD
Lenalidomide—Headache—Methotrexate—rheumatoid arthritis	1.36e-05	0.000107	CcSEcCtD
Lenalidomide—PTGS2—Spinal Cord Injury—IL6—rheumatoid arthritis	1.34e-05	0.000192	CbGpPWpGaD
Lenalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—rheumatoid arthritis	1.32e-05	0.000189	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—MED1—rheumatoid arthritis	1.29e-05	0.000186	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—TLE3—rheumatoid arthritis	1.29e-05	0.000185	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—BGN—rheumatoid arthritis	1.29e-05	0.000185	CbGpPWpGaD
Lenalidomide—Nausea—Methotrexate—rheumatoid arthritis	1.29e-05	0.000101	CcSEcCtD
Lenalidomide—ABCB1—Metabolism—PLD4—rheumatoid arthritis	1.27e-05	0.000183	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—ACAN—rheumatoid arthritis	1.23e-05	0.000176	CbGpPWpGaD
Lenalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—TGFB1—rheumatoid arthritis	1.21e-05	0.000174	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—ACP5—rheumatoid arthritis	1.2e-05	0.000172	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—B3GNT2—rheumatoid arthritis	1.2e-05	0.000172	CbGpPWpGaD
Lenalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—rheumatoid arthritis	1.19e-05	0.00017	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—SLC11A1—rheumatoid arthritis	1.18e-05	0.000169	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—NFATC1—rheumatoid arthritis	1.17e-05	0.000168	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—SLC25A12—rheumatoid arthritis	1.16e-05	0.000166	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—TP53—rheumatoid arthritis	1.15e-05	0.000165	CbGpPWpGaD
Lenalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—rheumatoid arthritis	1.13e-05	0.000162	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—GC—rheumatoid arthritis	1.13e-05	0.000161	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—PTGES—rheumatoid arthritis	1.13e-05	0.000161	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—NCF2—rheumatoid arthritis	1.09e-05	0.000156	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—BGN—rheumatoid arthritis	1.08e-05	0.000155	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—IL6—rheumatoid arthritis	1.05e-05	0.000151	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—PLB1—rheumatoid arthritis	1.05e-05	0.00015	CbGpPWpGaD
Lenalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—NFKB1—rheumatoid arthritis	1.03e-05	0.000148	CbGpPWpGaD
Lenalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—rheumatoid arthritis	1.01e-05	0.000145	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—SAA1—rheumatoid arthritis	1e-05	0.000144	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—ALOX5—rheumatoid arthritis	9.97e-06	0.000143	CbGpPWpGaD
Lenalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—rheumatoid arthritis	9.97e-06	0.000143	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—NCF1—rheumatoid arthritis	9.81e-06	0.000141	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—ENO1—rheumatoid arthritis	9.71e-06	0.000139	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—CD28—rheumatoid arthritis	9.43e-06	0.000135	CbGpPWpGaD
Lenalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—rheumatoid arthritis	9.35e-06	0.000134	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—MED1—rheumatoid arthritis	9.18e-06	0.000132	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—UBE2D1—rheumatoid arthritis	8.88e-06	0.000127	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism of lipids and lipoproteins—POMC—rheumatoid arthritis	8.77e-06	0.000126	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—ADRBK1—rheumatoid arthritis	8.61e-06	0.000123	CbGpPWpGaD
Lenalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—TGFB1—rheumatoid arthritis	8.59e-06	0.000123	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—B3GNT2—rheumatoid arthritis	8.53e-06	0.000122	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—ACP5—rheumatoid arthritis	8.53e-06	0.000122	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—ENO1—rheumatoid arthritis	8.13e-06	0.000116	CbGpPWpGaD
Lenalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—rheumatoid arthritis	8.02e-06	0.000115	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism of lipids and lipoproteins—ALB—rheumatoid arthritis	8e-06	0.000115	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—PRKCQ—rheumatoid arthritis	7.95e-06	0.000114	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—STAT1—rheumatoid arthritis	7.81e-06	0.000112	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—BGN—rheumatoid arthritis	7.68e-06	0.00011	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—ALOX5—rheumatoid arthritis	7.07e-06	0.000101	CbGpPWpGaD
Lenalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—rheumatoid arthritis	7.07e-06	0.000101	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—CCR5—rheumatoid arthritis	5.97e-06	8.55e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—CAT—rheumatoid arthritis	5.85e-06	8.39e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—MTHFR—rheumatoid arthritis	5.83e-06	8.36e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—HLA-A—rheumatoid arthritis	5.82e-06	8.33e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—ENO1—rheumatoid arthritis	5.76e-06	8.26e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Transmembrane transport of small molecules—ALB—rheumatoid arthritis	5.39e-06	7.72e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—IL6ST—rheumatoid arthritis	5.1e-06	7.31e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—NOS2—rheumatoid arthritis	5.06e-06	7.25e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—CD80—rheumatoid arthritis	4.91e-06	7.03e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—MTHFR—rheumatoid arthritis	4.88e-06	7e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—IL6R—rheumatoid arthritis	4.55e-06	6.52e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—CAT—rheumatoid arthritis	4.15e-06	5.94e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—TYK2—rheumatoid arthritis	4.14e-06	5.94e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—NOS3—rheumatoid arthritis	4.07e-06	5.83e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—POMC—rheumatoid arthritis	3.91e-06	5.6e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—CD4—rheumatoid arthritis	3.75e-06	5.37e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—ALB—rheumatoid arthritis	3.56e-06	5.1e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—MTHFR—rheumatoid arthritis	3.46e-06	4.96e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—NOS3—rheumatoid arthritis	3.41e-06	4.88e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—POMC—rheumatoid arthritis	2.77e-06	3.97e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—TGFB1—rheumatoid arthritis	2.69e-06	3.85e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—ALB—rheumatoid arthritis	2.52e-06	3.62e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—NOS3—rheumatoid arthritis	2.41e-06	3.46e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—PTGS2—rheumatoid arthritis	2.21e-06	3.16e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—IL6—rheumatoid arthritis	2.03e-06	2.9e-05	CbGpPWpGaD
